(Q83181725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

Duchenne muscular dystrophy

19 January 2020

main subject

1 reference

Yasuhiro Takeshima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mariko Yagi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hiroko Wada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kazuto Ishibashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Atsushi Nishiyama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mikio Kakumoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Toshiyuki Sakaeda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ryuichi Saura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Katsuhiko Okumura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Masafumi Matsuo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

690-694

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16627883%20AND%20SRC:MED&resulttype=core&format=json

Advances in Duchenne muscular dystrophy gene therapy

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Novel therapies for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Antisense oligonucleotides for cancer therapy-an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Applying antisense technology: Affinitak and other antisense oligonucleotides in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Bcl-2 antisense therapy in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Novel nonsense mutation (C-->A nt 10512) in exon 72 of dystrophin gene leading to exon skipping in a patient with a mild dystrophinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C

Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000215047.51278.7C